TY - JOUR
T1 - Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia
AU - Kishi, Taro
AU - Moriwaki, Masatsugu
AU - Kitajima, Tsuyoshi
AU - Kawashima, Kunihiro
AU - Okochi, Tomo
AU - Fukuo, Yasuhisa
AU - Furukawa, Osamu
AU - Naitoh, Hiroshi
AU - Fujita, Kiyoshi
AU - Iwata, Nakao
N1 - Funding Information:
Acknowledgements We thank Mr. S. Maeda, Ms. E. Nakamura, Ms. M. Tojo, Ms. Y Matsumoto, Ms. M. Tani, Ms. S. Isogai, Ms. M. Niwa, and Ms. Y. Kato for their technical support. This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology, the Ministry of Health, Labor, and Welfare, and the Japan Health Sciences Foundation (Research on Health Sciences focusing on Drug Innovation).
PY - 2010/4
Y1 - 2010/4
N2 - Background Studies have also shown that differences in the kind of the antipsychotics influenced disruption of the sensorimotor gating system, including prepulse inhibition (PPI), acoustic startle reflex (ASR), and habituation (HAB). We investigated the influence on startle response in chronic schizophrenia in 20 patients with schizophrenia taking risperidone, 21 patients with schizophrenia taking olanzapine, and 20 patients with schizophrenia taking aripiprazole. Method The patients who participated in this study were on maintenance therapy with only one antipsychotic drug for 4 months. We performed the test for the association between all PPI measures (ASR, HAB, and PPI at prepulse sound pressure intensities of 82, 86, and 90 dB) and each the risperidene, olanzapine, and aripiprazole groups, with analysis of covariance (ANCOVA; using age, duration of illness, and daily dose of the antipsychotic as covariates). Also, when significant difference was detected in ANCOVA, the differences of PPI measures between every pairs of two drug groups were tested as a post hoc analysis with the use of t test and Bonferroni's correction of multiple tests. Result We found that PPI90 showed significant differences with ANCOVA among patients with schizophrenia taking each of the antipsychotics. When we performed a post hoc analysis for PPI90, the value was higher in the aripiprazole group than in the olanzapine group and higher in the risperidone group than in the olanzapine group. Conclusion Aripiprazole and risperidone may improve PPI90. ASR, HAB, PPI82, and PPI86 were no different among the Japanese schizophrenic patient groups with different antipsychotics.
AB - Background Studies have also shown that differences in the kind of the antipsychotics influenced disruption of the sensorimotor gating system, including prepulse inhibition (PPI), acoustic startle reflex (ASR), and habituation (HAB). We investigated the influence on startle response in chronic schizophrenia in 20 patients with schizophrenia taking risperidone, 21 patients with schizophrenia taking olanzapine, and 20 patients with schizophrenia taking aripiprazole. Method The patients who participated in this study were on maintenance therapy with only one antipsychotic drug for 4 months. We performed the test for the association between all PPI measures (ASR, HAB, and PPI at prepulse sound pressure intensities of 82, 86, and 90 dB) and each the risperidene, olanzapine, and aripiprazole groups, with analysis of covariance (ANCOVA; using age, duration of illness, and daily dose of the antipsychotic as covariates). Also, when significant difference was detected in ANCOVA, the differences of PPI measures between every pairs of two drug groups were tested as a post hoc analysis with the use of t test and Bonferroni's correction of multiple tests. Result We found that PPI90 showed significant differences with ANCOVA among patients with schizophrenia taking each of the antipsychotics. When we performed a post hoc analysis for PPI90, the value was higher in the aripiprazole group than in the olanzapine group and higher in the risperidone group than in the olanzapine group. Conclusion Aripiprazole and risperidone may improve PPI90. ASR, HAB, PPI82, and PPI86 were no different among the Japanese schizophrenic patient groups with different antipsychotics.
UR - http://www.scopus.com/inward/record.url?scp=77952760363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952760363&partnerID=8YFLogxK
U2 - 10.1007/s00213-010-1787-x
DO - 10.1007/s00213-010-1787-x
M3 - Article
C2 - 20177883
AN - SCOPUS:77952760363
SN - 0033-3158
VL - 209
SP - 185
EP - 190
JO - Psychopharmacology
JF - Psychopharmacology
IS - 2
ER -